Antibody drug conjugate comprising nmt inhibitor and its use
AssigneesMyricX Pharma Limited, Imperial College Innovations Limited
InventorsRobin CARR, Roberto SOLARI, Edward William TATE, Andrew Simon BELL, Roger BONNERT
Life of this patent
Estimating the term…
Abstract
The present invention relates to ADCs comprising a NMT inhibitor conjugated to an antibody via a linker, and related uses.
Claims46
1-92. (canceled)
An antibody drug conjugate (ADC) comprising a NMT inhibitor conjugated to an antibody via a linker, or a salt thereof.
A drug conjugate or salt and/or solvate thereof comprising a NMT inhibitor and a linker, wherein the linker comprises a group capable of forming a covalent bond to a chain terminus or a functional group on an amino acid side chain of an antibody.
A compound selected from the group consisting of:
- a compound of formula (ADC-I):
- and
- a compound of formula (ADC-II):
- wherein NMT is the NMT inhibitor, or a salt and/or solvate of any one thereof.
Dependencies are inferred from the claim text.